Mp07-11 analysis of the clinical and cost-effectiveness of compounded fsh for male infertility treatment

Follicle-stimulating hormone (FSH) is a gonadotropin produced by the anterior pituitary gland and is trophic to the sertoli cells to maintain spermatogenesis. FSH is prescribed to men with hypogonadotropic hypogonadism (congenital or acquired) seeking fertility. Commercially available FSH, branded Gonal-F (B-FSH), is often cost prohibitive for patients, leading to the recent development of compounded alternatives. Here we compare the clinical and cost-effectiveness of B-FSH with compounded FSH (C-FSH).
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Infertility: Therapy II Source Type: research